Abbott Laboratories (ABT) Stock: Revenue, Earnings, Margins & Valuation
Abbott Laboratories (ABT), USA at a glance: revenue structure, segments, costs, margins and earnings from the latest published annual report (FY 2025), visualised as a Sankey diagram and complemented by price chart, P/E valuation and the original SEC filings. All figures in USD. Free and without signup.
Abbott Laboratories key figures (FY 2025)
| Revenue | 44.33 USD bn |
|---|---|
| Net income | 6.74 USD bn |
| Net margin | 15.2 % |
Abbott Laboratories revenue by segment (FY 2025)
| Segment | Revenue | Share |
|---|---|---|
| Established Pharmaceutical Products | 5.54 USD bn | 12.5 % |
| Nutritional Products | 8.45 USD bn | 19.1 % |
| Diagnostic Products | 8.94 USD bn | 20.2 % |
| Medical Devices | 21.39 USD bn | 48.3 % |
Abbott Laboratories earnings analysis
In the latest reported fiscal year (FY 2025), Abbott Laboratories generated revenue of 44.33 USD bn. The largest segment is Medical Devices with 21.39 USD bn, about 48.3 % of total segment revenue.
Abbott Laboratories business model
The income statement of Abbott Laboratories is visualised as a Sankey diagram: from revenue through cost of revenue and operating expenses to net income. The page also shows the price chart, the price-earnings ratio of the last five fiscal years, return on equity and the company's annual and quarterly filings.
More stock analyses like Abbott Laboratories
- AbbVie Inc. stock (ABBV)
- Advanced Micro Devices stock (AMD)
- Alphabet (Google) stock (GOOGL)
- Amazon.com Inc. stock (AMZN)
- American Express stock (AXP)
- Amgen Inc. stock (AMGN)
- Amphenol Corp. stock (APH)
- Apple Inc. stock (AAPL)
- Applied Materials Inc. stock (AMAT)
- AppLovin Corp. stock (APP)